(Q48396355)

English

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I.

scientific article published on 17 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

enzyme replacement therapy

0 references

Ingeborg Barisic

2

object named as

Ingeborg Barisic

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

author name string

Visnja Tokic

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

Nevenka Huzjak

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

Giorgie Petkovic

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

Ksenija Fumic

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

Eduard Paschke

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

publication date

17 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

European Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

166

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

727-732

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

https://scigraph.springernature.com/pub.10.1007/s00431-006-0316-8

0 references

Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of therapeutic proteins: clinical implications and future prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disordered breathing during sleep in patients with mucopolysaccharidoses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17043838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00431-006-0316-8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17043838

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48396355&oldid=1746405447"